MedPath

Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic

Not Applicable
Completed
Conditions
Anxiety
Depression
Distress, Emotional
Emotional Dysfunction
Interventions
Behavioral: Emotion Regulation Training via Telehealth
Registration Number
NCT04615416
Lead Sponsor
Teachers College, Columbia University
Brief Summary

This study is an open trial designed specifically to address the need for evidence-based treatment delivered via telehealth to individuals that are currently struggling with mental health issues during the COVID-19 pandemic, with the overarching goal of helping residents of New York adversely impacted by the pandemic to effectively manage their anxiety, stress, and depression during this unprecedented time in human history.

Detailed Description

The present study is evaluating whether this ERT treatment program delivered via telehealth demonstrates efficacy in: 1) reducing symptoms of psychological distress (e.g., anxiety, depression, worry, rumination); 2) improving outcomes specific to the ERT mechanism-based model (e.g., attentional control, decentering, reappraisal); 3) improving quality of life and functioning, for adults aged 18-65 years old.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
134
Inclusion Criteria
  • Aged 18-65 years during the time of participation
  • Endorses distress and worry/rumination exacerbated by the COVID-19 pandemic
  • Access to a mobile device (e.g., smartphone, personal computer, laptop, tablet) connected to the Internet
Exclusion Criteria
  • Active suicidal intent
  • Current substance dependence disorder (within the past year)
  • Current or past psychotic disorder, Bipolar-I disorder, or dementia
  • Primary DSM-5 diagnosis of borderline or narcissistic personality disorder
  • Currently receiving any other form of psychosocial treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Emotion Regulation Training via TelehealthEmotion Regulation Training via TelehealthAll participants will receive 9 sessions of Emotion Regulation Training delivered via telehealth. These individualized therapy sessions are 1-hour in length and occur semi-weekly over the course of four weeks.
Primary Outcome Measures
NameTimeMethod
Changes in Life Satisfaction: Patient-Reported Outcomes Measurement Information System (PROMIS): Meaning and PurposePre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 1-5 (minimum = 4; maximum = 20; higher scores indicate better outcomes)

Changes in Worry: Penn State Worry Questionnaire (PSWQ)Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 1-5 (minimum = 12; maximum = 60; higher scores indicate worse outcomes)

Changes in Rumination: Rumination-Reflection Questionnaire (RRQ)Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 1-5 (minimum = 12; maximum = 60; higher scores indicate worse outcomes)

Changes in Functional Impairment: Sheehan Disability Scale (SDS)Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 0-10 (minimum = 0; maximum = 30; higher scores indicate worse outcomes)

Changes in Life Satisfaction: Brief Multidimensional Students' Life Satisfaction Scale (BMSLSS)Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 1-6 (minimum = 5; maximum = 30; higher scores indicate better outcomes)

Changes in Anxiety, Depression, and Distress: Mood and Anxiety Symptoms Questionnaire (MASQ)Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 1-5 (minimum = 30; maximum = 150; higher scores indicate worse outcomes)

Changes in Anxiety, Depression, and Distress: Depression Anxiety Stress Scale (DASS)Pre-Treatment, Post-Treatment (4-5 weeks after starting treatment), 3-Month Follow-Up, 9-Month Follow-Up, 2-Year Follow-Up

Scale = 0-4 (minimum = 0; maximum = 84; higher scores indicate worse outcomes)

Secondary Outcome Measures
NameTimeMethod
Satisfaction and Usability of Treatment: Client Satisfaction Questionnaire (CSQ)Post-Treatment (4-5 weeks after starting treatment)

Scale = 1-4 (minimum = 4; maximum = 16; higher scores indicate better outcomes)

Semi-Weekly Measures of Treatment Changes in DistressSemi-weekly over the course of four weeks

Distress Thermometer (DT)

Semi-Weekly Measures of Treatment Changes in Rumination: Brief Rumination-Reflection Questionnaire (RRQ)Semi-weekly over the course of four weeks

Scale = 1-5 (minimum = 3; maximum = 15; higher scores indicate worse outcomes)

Semi-Weekly Measures of Treatment Changes in Metacognitive Regulation: Emotion Regulation Questionnaire (ERQ)Semi-weekly over the course of four weeks

Scale = 1-5 (minimum = 6; maximum = 30; higher scores indicate better outcomes)

Semi-Weekly Measures of Treatment Changes in Metacognitive Regulation: Experiences Questionnaire (EQ)Semi-weekly over the course of four weeks

Scale = 1-5 (minimum = 5; maximum = 25; higher scores indicate better outcomes)

Semi-Weekly Measures of Treatment Changes in Attentional Regulation: The Attentional Control Scale (ACS)Semi-weekly over the course of four weeks

Scale = 1-4 (minimum = 6; maximum = 24; higher scores indicate better outcomes)

Semi-Weekly Measures of Treatment Changes in Depression: Patient-Reported Outcomes Measurement Information System (PROMIS): DepressionSemi-weekly over the course of four weeks

Scale = 1-5 (minimum = 4; maximum = 20; higher scores indicate worse outcomes)

Semi-Weekly Measures of Treatment Changes in Depression SymptomsSemi-weekly over the course of four weeks

Quick Inventory of Depressive Symptoms(QUIDS)

Semi-Weekly Measures of Treatment Changes in Worry: Brief Penn State Worry Questionnaire (PSWQ)Semi-weekly over the course of four weeks

Scale: 1-5 (minimum = 3; maximum = 15; higher scores indicate worse outcomes)

Semi-Weekly Measures of Treatment Changes in Anxiety: Patient-Reported Outcomes Measurement Information System (PROMIS): AnxietySemi-weekly over the course of four weeks

Scale = 1-5 (minimum = 4; maximum = 20; higher scores indicate worse outcomes)

Trial Locations

Locations (1)

Teachers College, Columbia University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath